Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Costa, Sandra ^a   Pinto, Daniela ^b   Pereira, Deolinda ^b   Rodrigues, Helena ^b   Cameselle Teijeiro, Jorge ^c   Medeiros, Rui ^b,d   Schmitt, Fernando ^a,d  

^a UNIVERSITY OF MINHO   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^c HOSPITAL XERAL CÍES   (Spain)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; DNA;

ADULT; AGED; ANAMNESIS; ARTICLE; BREAST CANCER; CANCER RISK; CODON; CONTROLLED STUDY; FEMALE; GENE DUPLICATION; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; BREAST TUMOR; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CODON; DNA, NEOPLASM; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; LYMPHATIC METASTASIS; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 39849089291     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-32     Document Type: Article

References (50)

1. DeBruin LS Josephy PD Perspectives on the chemical etiology of breast cancer Environ Health Perspect 2002 110 Suppl 1:119-128 1241154 11834470
2. Dumitrescu RG Cotarla I Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med 2005, 9:208-221 10.1111/ j.1582-4934.2005.tb00350.x 15784178
3. Dapic V Carvalho MA Monteiro AN Breast cancer susceptibility and the DNA damage response Cancer Control 2005, 12:127-136 15855896
4. Ford D Easton DF Stratton M Narod S Goldgar D Devilee P Bishop DT Weber B Lenoir G Chang-Claude J Sobol H Teare MD Struewing J Arason A Scherneck S Peto J Rebbeck TR Tonin P Neuhausen S Barkardottir R Eyfjord J Lynch H Ponder BA Gayther SA Zelada-Hedman M. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 1998, 62:676-689 1376944 9497246 10.1086/301749
5. Lichtenstein P Holm NV Verkasalo PK Iliadou A Kaprio J Koskenvuo M Pukkala E Skytthe A Hemminki K Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 2000, 343:78-85 10.1056/ NEJM200007133430201 10891514
6. Feki A Irminger-Finger I Mutational spectrum of p53 mutations in primary breast and ovarian tumors Crit Rev Oncol Hematol 2004, 52:103-116 10.1016/j.critrevonc.2004.07.002 15501075
7. Gasco M Yulug IG Crook T TP53 mutations in familial breast cancer: functional aspects Hum Mutat 2003, 21:301-306 10.1002/humu.10173 12619116
8. Olivier M Goldgar DE Sodha N Ohgaki H Kleihues P Hainaut P Eeles RA Li-Fraumeni and related syndromes: Correlation between tumor type, family structure, and TP53 genotype Cancer Res 2003, 63:6643-6650 14583457
9. Jonkers J Meuwissen R van der GH Peterse H van V Berns A Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer Nat Genet 2001, 29:418-425 10.1038/ng747 11694875
10. Ongusaha PP Ouchi T Kim KT Nytko E Kwak JC Duda RB Deng CX Lee SW BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest Oncogene 2003, 22:3749-3758 10.1038/sj.onc.1206439 12802282
11. Xu Y Yao L Ouyang T Li J Wang T Fan Z Lin B Lu Y Xie Y p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer Clin Cancer Res 2005, 11:7328-7333 10.1158/1078-0432.CCR-05-0507 16243804
12. Tommiska J Eerola H Heinonen M Salonen L Kaare M Tallila J Ristimaki A von SK Aittomaki K Heikkila P Blomqvist C Nevanlinna H Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival Clin Cancer Res 2005, 11:5098-5103 10.1158/1078-0432.CCR-05-0173 16033823
13. Medeiros R Vasconcelos A Costa S Pinto D Lobo F Morais A Oliveira J Lopes C Linkage of angiotensin I-converting enzyme gene insertion/ deletion polymorphism to the progression of human prostate cancer J Pathol 2004, 202:330-335 10.1002/path.1529 14991898
14. Medeiros R Vasconcelos A Costa S Pinto D Morais A Oliveira J Lopees C Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer Cancer Genet Cytogenet 2003, 141:91-96 10.1016/ S0165-4608(02)00660-X 12606125
15. Pinto D Vasconcelos A Costa S Pereira D Rodrigues H Lopes C Medeiros R HER2 polymorphism and breast cancer risk in Portugal Eur J Cancer Prev 2004, 13:177-181 10.1097/01.cej.0000130015.91525.c7 15167216
16. Santos AM Sousa H Pinto D Portela C Pereira D Catarino R Duarte I Lopes C Medeiros R Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer Eur J Cancer 2006, 42:958-963 10.1016/j.ejca.2006.01.015 16542834
17. Olivier M Eeles R Hollstein M Khan MA Harris CC Hainaut P The IARC TP53 database: New online mutation analysis and recommendations to users Hum Mutat 2002, 19:607-614 10.1002/humu.10081 12007217
18. Pietsch EC Humbey O Murphy ME Polymorphisms in the p53 pathway Oncogene 2006, 25:1602-1611 10.1038/sj.onc.1209367 16550160
19. Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 1997, 349:1505-1510 10.1016/ S0140-6736(96)10109-4 9167459
20. Duarte F Cameselle-Teijeiro JF Soares R Seixas C Cortizo-Torres ME Perez-Villanueva J Schmitt FC [Analysis of mutations in genes BRCA1 and BRCA2 among patients with breast and ovarian cancer in northern Portugal and Galicia] Rev Clin Esp 2002, 202:259-263 12060539
21. Zhao LP Li LL Khalid N A method for assessing disease associations with SNP haplotypes and environmental variables in case-control Am J Hum Genet 2003, 72:1231-1250 1180275 12704570 10.1086/375140
22. Perou CM Sorlie T Eisen MB van de RM Jeffrey SS Rees CA Pollack JR Ross DT Johnsen H Akslen LA Fluge O Pergamenschikov A Williams C Zhu SX Lonning PE Borresen-Dale AL Brown PO Botstein D Molecular portraits of human breast tumours Nature 2000, 406:747-752 10.1038/35021093 10963602
23. Medeiros R Vasconcelos A Costa S Pinto D Ferreira P Lobo F Morais A Oliveira J Lopes C Metabolic susceptibility genes and prostate cancer risk in a southern European population: The role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms Prostate 2004, 58:414-420 10.1002/pros.10348 14968442
24. Costa S Pinto D Morais A Vasconcelos A Oliveira J Lopes C Medeiros R Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population Prostate 2005, 64:246-252 10.1002/ pros.20241 15717312
25. Costa S Pinto D Pereira D Vasconcelos A fonso-Lopes C Osorio T Lopes C Medeiros R Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer Cancer Lett 2006, 246:324-330 10.1016/ j.canlet.2006.03.014 16677755
26. Gaudet MM Bensen JT Schroeder J Olshan AF Terry MB Eng SM Teitelbaum SL Britton JA Lehman TA Neugut AI Ambrosone CB Santella RM Gammon MD Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York Breast Cancer Res Treat 2006, 99:235-240 10.1007/ s10549-006-9205-0 16596327
27. Shin A Shu XO Cai Q Gao YT Zheng W Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: A possible dual role at different cancer stages Cancer Epidemiol Biomarkers Prev 2005, 14:1567-1570 10.1158/1055-9965.EPI-05-0078 15941974
28. Dufloth RM Costa S Schmitt F Zeferino LC DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil Genet Mol Res 2005, 4:771-782 16475125
29. Lee KM Choi JY Park SK Chung HW Ahn B Yoo KY Han W Noh DY Ahn SH Kim H Wei Q Kang D Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk Cancer Epidemiol Biomarkers Prev 2005, 14:821-825 10.1158/1055-9965.EPI-04-0330 15824150
30. Siddique M Sabapathy K Trp53-dependent DNA-repair is affected by the codon 72 polymorphism Oncogene 2006, 25:3489-3500 10.1038/sj.onc.1209405 16462765
31. Pim D Banks L p53 polymorphic variants at codon 72 exert different effects on cell cycle progression Int J Cancer 2004, 108:196-199 10.1002/ ijc.11548 14639602
32. Dumont P Leu JI Della PAC III George DL Murphy M The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat Genet 2003, 33:357-365 10.1038/ng1093 12567188
33. Wang-Gohrke S Becher H Kreienberg R Runnebaum IB Chang-Claude J Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years Pharmacogenetics 2002, 12:269-272 10.1097/00008571-200204000-00012 11927843
34. Lewis R Human Genetics New York, McGraw-Hill 4 2001, 12:228-232
35. Mabrouk I Baccouche S El-Abed R Mokdad-Gargouri R Mosbah A Said S Daoud J Frikha M Jlidi R Gargouri A No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients Ann N Y Acad Sci 2003, 1010:764-770 10.1196/ annals.1299.137 15033824
36. Suspitsin EN Buslov KG Grigoriev MY Ishutkina JG Ulibina JM Gorodinskaya VM Pozharisski KM Berstein LM Hanson KP Togo AV Imyanitov EN Evidence against involvement of p53 polymorphism in breast cancer predisposition Int J Cancer 2003, 103:431-433 10.1002/ijc.10834 12471629
37. Bonafe M Ceccarelli C Farabegoli F Santini D Taffurelli M Barbi C Marzi E Trapassi C Storci G Olivieri F Franceschi C Retention of the p53 Codon 72 Arginine Allele Is Associated with a Reduction of Disease-Free and Overall Survival in Arginine/Proline Heterozygous Breast Cancer Patients Clin Cancer Res 2003, 9:4860-4864 14581358
38. Ohayon T Gershoni-Baruch R Papa MZ Distelman MT Eisenberg BS Friedman E The R72P P53 mutation is associated with familial breast cancer in Jewish women Br J Cancer 2005, 92:1144-1148 10.1038/sj.bjc.6602451 15756275
39. Buyru N Tigli H Dalay N P53 codon 72 polymorphism in breast cancer Oncol Rep 2003, 10:711-714 12684648
40. Thomas M Kalita A Labrecque S Pim D Banks L Matlashewski G Two polymorphic variants of wild-type p53 differ biochemically and biologically Mol Cell Biol 1999, 19:1092-1100 116039 9891044
41. Martin AM Kanetsky PA Amirimani B Colligon TA Athanasiadis G Shih HA Gerrero MR Calzone K Rebbeck TR Weber BL Germline TP53 mutations in breast cancer families with multiple primary cancers: Is TP53 a modifier of BRCA1? J Med Genet 2003, 40:e34 10.1136/jmg.40.4.e34 12676907
42. Osorio A Martinez-Delgado B Pollan M Cuadros M Urioste M Torrenteras C Melchor L Diez O de la HM Velasco E Gonzalez-Sarmiento R Caldes T Alonso C Benitez J A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers Hum Mutat 2006, 27:242-248 10.1002/humu.20283 16419081
43. Sengupta S Harris CC p53: Traffic cop at the crossroads of DNA repair and recombination Nat Rev Mol Cell Biol 2005, 6:44-55 10.1038/nrm1546 15688066
44. Weston A Pan CF Ksieski HB Wallenstein S Berkowitz GS Tartter PI Bleiweiss IJ Brower ST Senie RT Wolff MS p53 haplotype determination in breast cancer Cancer Epidemiol Biomarkers Prev 1997, 6:105-112 9037561
45. Mattick JS Introns: Evolution and function Curr Opin Genet Dev 1994, 4:823-831 10.1016/0959-437X(94)90066-3 7888751
46. Mattick JS Rna Regulation: A new genetics? Nat Rev Genet 2004, 5:316 10.1038/nrg1321 15131654
47. Gemignani F Moreno V Landi S Moullan N Chabrier A Gutierrez-Enriquez S Hall J Guino E Peinado MA Capella G Canzian F A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA Oncogene 2004, 23:1954-1956 10.1038/sj.onc.1207305 14647431
48. Wu X Zhao H Amos CI Shete S Makan N Hong WK Kadlubar FF Spitz MR p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity J Natl Cancer Inst 2002, 94:681-690 11983757
49. Birgander R Sjalander A Rannug A Alexandrie AK Sundberg MI Seidegard J Tornling G Beckman G Beckman L P53 polymorphisms and haplotypes in lung cancer Carcinogenesis 1995, 16:2233-2236 10.1093/carcin/16.9.2233 7554081
50. Sjalander A Birgander R Hallmans G Cajander S Lenner P Athlin L Beckman G Beckman L p53 polymorphisms and haplotypes in breast cancer Carcinogenesis 1996, 17:1313-1316 10.1093/carcin/17.6.1313 8681448